Mesoblast (ASX:MSB) has announced that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...
“Similar changes have been made to the Catalyst Fund, and reflect a similar short sightedness. International collaboration is most effective around fundamental research in areas of mutual excellence ...